ATE526030T1 - Protein s zur verwendung als neuroprotektives mittel - Google Patents
Protein s zur verwendung als neuroprotektives mittelInfo
- Publication number
- ATE526030T1 ATE526030T1 AT03799306T AT03799306T ATE526030T1 AT E526030 T1 ATE526030 T1 AT E526030T1 AT 03799306 T AT03799306 T AT 03799306T AT 03799306 T AT03799306 T AT 03799306T AT E526030 T1 ATE526030 T1 AT E526030T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- stroke
- activities
- agents
- oxygenation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8128—Antithrombin III
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41433302P | 2002-09-30 | 2002-09-30 | |
PCT/US2003/030638 WO2004030619A2 (en) | 2002-09-30 | 2003-09-30 | Protein s protects the nervous system from injury |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE526030T1 true ATE526030T1 (de) | 2011-10-15 |
Family
ID=32069725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03799306T ATE526030T1 (de) | 2002-09-30 | 2003-09-30 | Protein s zur verwendung als neuroprotektives mittel |
Country Status (6)
Country | Link |
---|---|
US (1) | US7968515B2 (de) |
EP (1) | EP1572134B1 (de) |
AT (1) | ATE526030T1 (de) |
AU (1) | AU2003277034A1 (de) |
CA (1) | CA2499458C (de) |
WO (1) | WO2004030619A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004030619A2 (en) | 2002-09-30 | 2004-04-15 | Socratech L.L.C. | Protein s protects the nervous system from injury |
WO2007018400A1 (en) * | 2005-08-11 | 2007-02-15 | Medigenes Co., Ltd | Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum |
CN104122396A (zh) * | 2013-04-23 | 2014-10-29 | 中国科学院上海生命科学研究院 | 维生素k依赖性蛋白s作为糖尿病标志物的应用 |
DE102013209820A1 (de) | 2013-05-27 | 2014-11-27 | Hamm Ag | Selbstfahrende Straßenbaumaschine, insbesondere Straßenwalze, sowie Verfahren zum Fahren und Lenken einer Straßenbaumaschine |
US11007254B2 (en) | 2016-10-17 | 2021-05-18 | Musc Foundation For Research Development | Compositions and methods for treating central nervous system injury |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534617A (en) | 1988-10-28 | 1996-07-09 | Genentech, Inc. | Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
US5254532A (en) * | 1989-06-26 | 1993-10-19 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
US5321123A (en) | 1991-07-02 | 1994-06-14 | The Scripps Research Institute | Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods |
US5405946A (en) | 1992-12-02 | 1995-04-11 | The Scripps Research Institute | Recombinant protein S variants deficient in C4BP binding activity, compositions and therapeutic methods |
AU6985594A (en) | 1993-06-30 | 1995-01-24 | Bonno Nammen Bouma | Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
DE4418635C2 (de) | 1994-05-27 | 1997-07-24 | Immuno Ag | Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen |
DE19531637A1 (de) | 1995-08-28 | 1997-03-06 | Immuno Ag | Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung |
WO1997016169A1 (en) * | 1995-11-01 | 1997-05-09 | Chiron Corporation | Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space |
US6379975B1 (en) | 1996-11-27 | 2002-04-30 | T.A.C. Thrombosis And Coagulation Aktiebolag | Methods and reagents for determining protein S |
AU2001238034A1 (en) | 2000-02-04 | 2001-08-14 | The Scripps Research Institute | Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
US20030165485A1 (en) * | 2001-11-09 | 2003-09-04 | Goran Bertilsson | Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells |
WO2004030619A2 (en) | 2002-09-30 | 2004-04-15 | Socratech L.L.C. | Protein s protects the nervous system from injury |
WO2004056309A2 (en) | 2002-12-05 | 2004-07-08 | Socratech L.L.C. | Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
US20070142272A1 (en) | 2003-01-24 | 2007-06-21 | Zlokovic Berislav V | Neuroprotective activity of activated protein c independent of its anticoagulant activity |
-
2003
- 2003-09-30 WO PCT/US2003/030638 patent/WO2004030619A2/en not_active Application Discontinuation
- 2003-09-30 AT AT03799306T patent/ATE526030T1/de not_active IP Right Cessation
- 2003-09-30 US US10/529,748 patent/US7968515B2/en not_active Expired - Fee Related
- 2003-09-30 EP EP03799306A patent/EP1572134B1/de not_active Expired - Lifetime
- 2003-09-30 CA CA2499458A patent/CA2499458C/en not_active Expired - Fee Related
- 2003-09-30 AU AU2003277034A patent/AU2003277034A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2499458C (en) | 2013-11-12 |
AU2003277034A8 (en) | 2004-04-23 |
US7968515B2 (en) | 2011-06-28 |
EP1572134B1 (de) | 2011-09-28 |
EP1572134A4 (de) | 2008-07-09 |
WO2004030619A8 (en) | 2004-11-25 |
WO2004030619A3 (en) | 2005-06-02 |
EP1572134A2 (de) | 2005-09-14 |
US20060052281A1 (en) | 2006-03-09 |
WO2004030619A2 (en) | 2004-04-15 |
CA2499458A1 (en) | 2004-04-15 |
AU2003277034A1 (en) | 2004-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60335244D1 (de) | Behandlung von verletzungen des zentralen nervensystems | |
ATE398459T1 (de) | Verwendung von naip oder iap für die behandlung und vorbeugung von neuronalen erkrankungen | |
ATE381935T1 (de) | Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen | |
WO2000027422A3 (en) | Methods and compositions for treating or preventing peripheral neuropathies | |
DE60216139D1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
NO20053855L (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
BR0313239A (pt) | Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças | |
BR0307508A (pt) | Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença | |
DE69943287D1 (de) | Antibiotische zusammensetzung, die moxifloxacin enthält, zur behandlung von augen | |
WO2002036829A3 (en) | Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries | |
DE69432299D1 (de) | Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen | |
DE69433309D1 (de) | Verbeugende oder therapeutische Mittel für die Alzheimer-Krankheit, eine Siebtest-Methode, und die menschliche Tau-Protein-Kinase | |
WO2004096216A3 (en) | Use of a topical medicament comprising riluzole | |
DE69633336D1 (de) | Zusamenzetzung enthaltend einen inhibitor des myelin assoziierten glycoproteins (mag), welcher einer veränderten oder mutierten form von mag enthält | |
ATE504310T1 (de) | Neuroprotektive, antithrombotische und anti- entzündliche anwendungen von aktiviertem protein c | |
BR0201862A (pt) | Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos | |
ATE526030T1 (de) | Protein s zur verwendung als neuroprotektives mittel | |
DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
HK1063601A1 (en) | Compositions and methods for treating hyperimmune response in the eye | |
EP1186672A3 (de) | Polymorphismen im Gen für den humanen organischen Anionentransporter C (OATP-C) | |
DE59710517D1 (de) | Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae | |
WO2003039487A3 (en) | Cyclo(prolyl-glycine) and methods of use to treat neural disorders | |
DE602004021933D1 (de) | 4-brom-5-(2-chlor-benzoylamino)-1h-pyrazol-3-carbonsäure(phenyl)amid-derivate und verwandte verbindungen als bradykinin b1 receptor antagonisten zur behandlung von entzündlichen erkrankungen | |
CA2534303A1 (en) | Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |